Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.

Gian Poalo Fadini Anna SoliniMaria Laura MancaGiuseppe PennoAdriano GattiRoberto AnichiniStephano Del Prato Angelo Avogaronull null

Published in: Diabetes, obesity & metabolism (2018)

The antiproteinuric effect of dapagliflozin is confirmed here for the first time by real-world data. Despite a mild decline in eGFR, there was no evidence of clinically relevant worsening in renal function.

Keyphrases

small cell lung cancer
randomized controlled trial
epidermal growth factor receptor
systematic review
tyrosine kinase
electronic health record
clinical trial
study protocol
big data
cross sectional
machine learning
artificial intelligence